Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attr...
Mario Hose | April 16, 2020 |

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. This morning, biotherapeutics company aTyr Pharma I...
Streetwise Reports | January 7, 2020 |

EMA Opinion Bodes Well for Biopharma's Drug Getting Orphan Status

The designation, opinion and asset are discussed in a ROTH Capital Partners report. In a July 29 research note, ROTH Capital Partners analyst Scott Henry reported that Anavex Life Sciences Corp. (AVXL:NASDAQ) is pursuing orphan status from the European Med...
Streetwise Reports | August 1, 2019 |

Reata Pharma Announces $350 Million Strategic Investment from Blackstone Life Sciences

Shares of Reata Pharmaceuticals traded 30% higher after reporting that Blackstone Life Sciences will invest $350 million in the company to advance bardoxolone methyl as a potential therapy for Alport syndrome and other rare and serious chronic kidney diseases. Clin...
Streetwise Reports | June 12, 2020 |

China’s Social Credit System - It’s Coming to the United States

In 2015, a 16-year-old student from Jiangsu, China, tried to board a train. She couldn’t even purchase a ticket. The student, Zhong Pei, tried enrolling in classes at her university. But she was not allowed to do that either.   Zhong had committed a serious ...
Marin Katusa | March 1, 2019 |

Riverside Resources – Strategic, Accretive, and Blue Sky

Riverside Resources (TSX.V: RRI | OTCQB: RVSDF ) In this exclusive interview, Dr. John-Mark Staude of Riverside Resources sits down with Maurice Jackson of Proven and Probable to discuss the strategic acquisition the company has made to expand the property bank footp...
Maurice Jackson | September 25, 2019 |

Crossing the Rubicon into the Super Premium Cannabis Space

Rubicon Organics Inc. ( CSE: ROMJ , OTCQX: ROMJF , Forum ) is a licensed cannabis producer focused on cultivating and branding certified organic, super-premium cannabis. Rubicon trades on the Canadian Securities Exchange under the symbol ROMJ. In this fascina...
Dave Jackson | April 3, 2020 |

Cultivating. Innovating. Operating: Discovering the Science of CBD

Sire Bioscience Inc’s ( CSE.SIRE , OTC: BLLXF , Forum ) business model is based on their ability to engage in the investment, production, and sale of hemp for CBD extraction. That’s the desirable scalable endgame for any cannabis company....
Dave Jackson | May 13, 2020 |

Crude Cuts Get Another Saudi Boost as Oil Demand Begins to Show Signs of Life

Saudi Arabia enhanced their commitment to OPEC+ supply cuts as the Kingdom said they'd shut production of additional 1 million barrels of crude oil per day next month. Most of the OPEC+ countries have already come close to compliance with the deal that took effect this mo...
Streetwise Reports | May 22, 2020 |

Next Bull and Bear Markets are Now Set Up

Sharing market analysis and my opinions every day is far from easy and sometimes I feel like a song on repeat. My focus and goal has always been to try to alert fellow traders and investors of what is unfolding now in the financial markets around the globe because it appears w...
Chris Vermeulen | June 25, 2019 |
1 2 3 4 5 6 7 8 9 10 ...